Edition:
India

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

3.38USD
1:30am IST
Change (% chg)

$0.45 (+15.36%)
Prev Close
$2.93
Open
$2.94
Day's High
$3.38
Day's Low
$2.85
Volume
27,933
Avg. Vol
62,896
52-wk High
$10.98
52-wk Low
$1.85

Latest Key Developments (Source: Significant Developments)

U.S. Awards Diffusion Rights For Use Of TSC Along With Stroke Therapeutic
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Diffusion Pharmaceuticals Inc ::U.S. PATENT OFFICE AWARDS DIFFUSION EXCLUSIVE RIGHTS FOR USE OF TSC IN CONJUNCTION WITH ONLY FDA-APPROVED STROKE THERAPEUTIC.  Full Article

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.DIFFUSION PHARMACEUTICALS INC - HAD CASH AND CASH EQUIVALENTS OF $11.0 MILLION AS OF SEPTEMBER 30.DIFFUSION PHARMACEUTICALS - BELIEVES CASH AND CASH EQUIVALENTS AT SEPT 30 ARE SUFFICIENT TO FUND OPERATIONS THROUGH SEPT 2019.DIFFUSION PHARMACEUTICALS - RECOGNIZED NON-CASH GOODWILL IMPAIRMENT CHARGE OF $4.2 MILLION IN QUARTER.DIFFUSION PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.13.  Full Article

Diffusion Pharmaceuticals ‍Had Cash And Cash Equivalents Of $8.9 Mln AS OF Dec 31, 2017​
Tuesday, 3 Apr 2018 

April 3 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.‍HAD CASH AND CASH EQUIVALENTS OF $8.9 MILLION AS OF DECEMBER 31, 2017​.  Full Article

Diffusion Pharmaceuticals Files Prospectus Related To Offering Of Common Stock
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​.  Full Article

Diffusion Pharma Files For Stock Offering For Up To About $15 Mln
Thursday, 21 Dec 2017 

Dec 20 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS FILES FOR STOCK OFFERING FOR UP TO ABOUT $15 MILLION - SEC FILING.  Full Article

Diffusion Pharmaceuticals reports qtrly net income per diluted share $0.20‍​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals Inc qtrly net income per diluted share $0.20‍​.Diffusion Pharmaceuticals Inc - ‍remain on track to begin enrolling patients by end of 2017 for tsc glioblastoma phase 3 pivotal study​.Diffusion Pharmaceuticals Inc - ‍awaiting confirmation from Nasdaq that co demonstrated compliance with all applicable requirements for continued listing​.  Full Article

Diffusion Pharma gets FDA protocol guidance for phase 3 trial with TSC
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals receives final FDA protocol guidance for phase 3 clinical trial with TSC in patients newly diagnosed with inoperable glioblastoma multiforme.Has responded to all outstanding points raised by FDA, plans to begin trial under protocol agreed to by FDA by end of 2017​.Trial to compare survival at 2 yrs of patients receiving TSC concurrent with chemo, radiation with patients receiving SOC alone​.  Full Article

Diffusion Pharmaceuticals Q2 loss per share $1.00
Tuesday, 15 Aug 2017 

Aug 14 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals reports second quarter 2017 financial results and provides business update.Qtrly loss per share $1.00.  Full Article

Diffusion Pharma achieves drug production milestone
Thursday, 20 Jul 2017 

July 20 (Reuters) - Diffusion Pharmaceuticals Inc ::Diffusion Pharmaceuticals achieves drug production milestone for planned phase 3 clinical trial in inoperable GBM brain cancer.Says ‍diffusion plans to initiate this clinical trial by end of 2017​.Diffusion Pharmaceuticals- interacting with FDA regarding design, execution of planned phase 3 study, with initiation planned for later this year​.Diffusion-Planned studies include phase 2 trials in pancreatic cancer, brain metastases; initiation subject to receipt of funding/collaborative partnering.  Full Article

Diffusion Pharmaceuticals files for offering up to 26.5 mln shares
Thursday, 18 May 2017 

May 17 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals Inc files for offering up to 26.5 million shares of common stock by the selling stockholders - SEC filing.  Full Article